Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III evaluation of the safety and efficacy of Clonicel (clonidine HCl sustained release) as add-on to psychostimulant medication vs. psychostimulant medication alone in children and adolescents with ADHD

Next Previous
Trial Profile

Phase III evaluation of the safety and efficacy of Clonicel (clonidine HCl sustained release) as add-on to psychostimulant medication vs. psychostimulant medication alone in children and adolescents with ADHD

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Jun 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clonidine (Primary) ; Central nervous system stimulants
  • Indications Attention-deficit hyperactivity disorder
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Addrenex Pharmaceuticals

Most Recent Events

  • 09 May 2011 Results published in the Pediatrics.
  • 09 May 2011 Results have been published in Pediatrics according to a Shionogi media release.
  • 04 Oct 2010 The US FDA has approved clonidine extended-release tablets based on results from this and another (32491) trial, according to a Shinogi Pharma media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top